focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.60
Bid: 368.40
Ask: 368.80
Change: 1.20 (0.33%)
Spread: 0.40 (0.109%)
Open: 360.20
High: 369.20
Low: 360.20
Prev. Close: 367.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

14 Feb 2024 07:00

RNS Number : 0353D
QinetiQ Group plc
14 February 2024
 

QinetiQ Group plc

14th February 2024

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that on 13th February 2024 it has purchased, in accordance with the authority granted by shareholders at the general meeting of the Company held on 6 February 2024, the following number of its ordinary shares of 1 pence each (Shares) on the London Stock Exchange pursuant to its existing £100 million share buyback programme which was announced on 16 January 2024.

The Company intends to cancel the purchased shares.

Description of Shares:

QinetiQ Group plc- ordinary shares of 1 pence each (ISIN: GB00B0WMWD03)

Date of transaction

13th February 2024

Number of Shares purchased:

100,000

Average price paid per Share (pence):

369.9477

Highest price paid per Share (pence):

373.0000

Lowest price paid per Share (pence):

368.6000

Broker:

Barclays Capital Securities Limited

 

Aggregate information:

Venue

Volume-weighted average price

Aggregated volume

Lowest price per share

Highest price per share

Aquis Exchange

3.6944

10,924

3.6860

3.7160

CBOE BXE

3.7085

2,626

3.6880

3.7200

CBOE CXE

3.7019

25,681

3.6860

3.7240

London Stock Exchange

3.6993

56,291

3.6860

3.7300

Turquoise

3.6944

 4,478

3.6860

3.7020

 

This announcement is prepared on a trade basis. It is expected the shares purchased will be delivered to the Company within two working days. The total voting rights referred to below is prepared on a settlement basis.

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 578,067,121. The Company does not hold any ordinary shares in treasury. Therefore, the total voting rights in the Company will be 578,067,121.

The figure of 578,067,121 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company is available via the link below.

 http://www.rns-pdf.londonstockexchange.com/rns/0353D_1-2024-2-13.pdf

This announcement will also be available on QinetiQ Group plc's website at https://www.qinetiq.com/en/investors.

Enquiries to:

John Haworth, Group Head of Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: ? +44 (0) 7793 427582

James Field, Company Secretary: ? +44 (0) 7841 662957

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKNBPOBKDQBD
Date   Source Headline
1st Jul 201611:18 amRNSDirector/PDMR Shareholding
1st Jul 20167:00 amRNSTotal Voting Rights
30th Jun 20166:10 pmRNSTransaction in Own Shares
29th Jun 20165:42 pmRNSTransaction in Own Shares
29th Jun 20167:05 amRNSDirectorate Change
28th Jun 20165:49 pmRNSTransaction in Own Shares
28th Jun 20164:02 pmRNSDirector/PDMR Shareholding
27th Jun 20165:53 pmRNSTransaction in Own Shares
24th Jun 20164:54 pmRNSTransaction in Own Shares
14th Jun 201611:05 amRNSAnnual Financial Report and Notice of AGM
10th Jun 20165:28 pmRNSNon-Executive Chairman Declaration
10th Jun 20164:33 pmRNSDirector/PDMR Shareholding
26th May 20167:00 amRNSFull year results 2016
18th May 20164:41 pmRNSHolding(s) in Company
10th May 20161:57 pmRNSDirector/PDMR Shareholding
3rd May 20164:50 pmRNSBlock listing Interim Review
13th Apr 201612:23 pmRNSDirector/PDMR Shareholding
31st Mar 20169:58 amRNSTotal Voting Rights
24th Mar 20167:00 amRNSPre Close Statement
16th Mar 20165:03 pmRNSTransaction in Own Shares
15th Mar 20165:04 pmRNSTransaction in Own Shares
14th Mar 20165:22 pmRNSTransaction in Own Shares
11th Mar 20165:37 pmRNSTransaction in Own Shares
10th Mar 20165:10 pmRNSTransaction in Own Shares
10th Mar 20162:24 pmRNSDirector/PDMR Shareholding
9th Mar 20165:35 pmRNSTransaction in Own Shares
8th Mar 20165:34 pmRNSTransaction in Own Shares
7th Mar 20165:00 pmRNSTransaction in Own Shares
4th Mar 20165:16 pmRNSTransaction in Own Shares
3rd Mar 20165:06 pmRNSTransaction in Own Shares
2nd Mar 20165:25 pmRNSTransaction in Own Shares
1st Mar 20165:55 pmRNSTransaction in Own Shares
29th Feb 20165:04 pmRNSTransaction in Own Shares
29th Feb 201611:38 amRNSTotal Voting Rights
23rd Feb 20169:46 amRNSDirector/PDMR Shareholding
15th Feb 20161:47 pmRNSDirector/PDMR Shareholding
11th Feb 20167:00 amRNSAdoption of FRS 101 - Reduced Disclosure Framework
10th Feb 20163:46 pmRNSDirector/PDMR Shareholding
10th Feb 20163:45 pmRNSDirector/PDMR Shareholding
10th Feb 20167:00 amRNSThird Quarter Trading Update
9th Feb 20165:17 pmRNSTransaction in Own Shares
27th Jan 20169:02 amRNSDirectorate Change
12th Jan 20163:11 pmRNSDirector/PDMR Shareholding
15th Dec 20154:20 pmRNSDirector/PDMR Shareholding
11th Dec 20156:00 pmRNSDisposal
19th Nov 20157:00 amRNSHalf Yearly Report
10th Nov 20154:21 pmRNSDirector/PDMR Shareholding
2nd Nov 201510:30 amRNSBlocklisting Interim Review
12th Oct 20153:28 pmRNSDirector/PDMR Shareholding
5th Oct 20155:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.